Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001321092.3(GPS1):c.206C>T(p.Thr69Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000093 in 1,612,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
GPS1 (HGNC:4549): (G protein pathway suppressor 1) This gene is known to suppress G-protein and mitogen-activated signal transduction in mammalian cells. The encoded protein shares significant similarity with Arabidopsis FUS6, which is a regulator of light-mediated signal transduction in plant cells. [provided by RefSeq, Mar 2016]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.326C>T (p.T109M) alteration is located in exon 3 (coding exon 3) of the GPS1 gene. This alteration results from a C to T substitution at nucleotide position 326, causing the threonine (T) at amino acid position 109 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
.;.;.;.;Loss of phosphorylation at T69 (P = 0.0716);.;Loss of phosphorylation at T69 (P = 0.0716);.;.;.;Loss of phosphorylation at T69 (P = 0.0716);.;Loss of phosphorylation at T69 (P = 0.0716);.;.;.;